Menu

Home / Guides / Contrave vs. semaglutide

Daily pill or weekly shot?

Contrave vs. Semaglutide (2026): Which Fits You, and What Each Costs

By the NexLife Medical Team · Medically reviewed by Adam Kennah, MD (NPI 1144260043) · Updated

Wegovy, a weekly semaglutide shot, led to more weight loss in separate trials (14.9% vs 5.4% on Contrave), while Contrave, a twice-daily pill, usually costs less: $99 a month by home delivery, against $349 self-pay (checked November 1, 2026). Your history often decides which fits you. Compounded semaglutide, which isn’t FDA-approved, is $95 a month at NexLife on the 12-month plan, or $109 month to month.

  • Contrave: a pill twice a day, $99 a month by home delivery
  • Wegovy: a weekly shot, $349 a month self-pay
  • Medicare’s Bridge: covers Wegovy, not Contrave
Published by NexLifeLegitScript-certified
NexLifeSame price at every dose
Illustration of a compounded semaglutide vial

$95/mo on a 12-month plan, all-inclusive, same price at every dose

Or $109/mo month to month

Brand-name Wegovy: $149 to $399 a month self-pay, pill or pen

Check my eligibility

About 3 minutes of health questions · No insurance needed · Not prescribed? No charge for medication

See all 4 plans and what a year costs
Compounded semaglutide, all in, the same price at every dose
PlanPer month12 months at this rate
12-month Most savings$95$1,140
6-month$99$1,188
3-month$105$1,260
Month to month$109$1,308

Month to month costs $168 more over 12 months than the 12-month plan. Plans renew until you cancel. Month to month is billed monthly. The 3-, 6- and 12-month plans are paid upfront at checkout: $315, $594 or $1,140.

Price Match Guarantee†. Paying less elsewhere? We match your regular monthly price. How it works

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026)LegitScript-certified

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. The vial shown is an illustration. Always use the strength on your pharmacy’s label.

  • Licensed U.S. providers
  • LegitScript certified
  • Free expedited shipping
  • HSA, FSA, Affirm, Klarna, Afterpay
  • 24/7 support, real people
  • Filled by Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA)

Compounded semaglutide isn’t FDA-approved, isn’t a generic and isn’t Wegovy. A licensed provider prescribes it only when it offers a significant difference for you. NexLife doesn’t offer Contrave.

The short version

How do Contrave and semaglutide compare?

Contrave vs. semaglutide at a glance: what each is, weight loss in their separate main trials, the most common side effect, the boxed warnings, self-pay prices checked November 1, 2026, and Medicare
QuestionAnswer
What are they?Contrave: naltrexone plus bupropion, in a pill. Semaglutide: a GLP-1 medicine, sold for weight as Wegovy, a weekly shot or a pill.
Weight loss in trials?Separate trials: 5.4% on Contrave at 56 weeks, vs 1.3% on placebo (COR-I, 2010); 14.9% on Wegovy at 68 weeks, vs 2.4% (STEP 1, 2021)
Most common side effect?Nausea: 32.5% on Contrave (6.7% on placebo); 44% on Wegovy 2.4 mg (16%)
Boxed warning?Contrave: suicidal thoughts and behaviors. Semaglutide: thyroid C-cell tumors, seen in rodents.
Self-pay price?Contrave $99 a month by home delivery; Wegovy pen $349 a month (checked November 1, 2026)
Medicare?The $50 GLP-1 Bridge covers Wegovy for people who qualify, not Contrave
  1. Tell us about you About 3 minutes of health questions
  2. A licensed provider decides You’re prescribed only if it’s right for you
  3. Your partner pharmacy ships Usually within 1 to 2 business days, free

Key takeaways

  • In separate trials, people lost more on Wegovy: 14.9% on average in STEP 1, vs 5.4% on Contrave in COR-I.
  • Not head-to-head: STEP 1 ran 68 weeks and COR-I 56; placebo groups lost 2.4% and 1.3%.
  • Nausea leads on both: 32.5% on Contrave and 44% on Wegovy 2.4 mg, against 6.7% and 16% on placebo.
  • Each has a boxed warning: suicidal thoughts and behaviors for Contrave, from bupropion; thyroid C-cell tumors in rodents for semaglutide.
  • Contrave usually costs less: $99 a month by home delivery, against $349 for Wegovy pens self-pay (checked November 1, 2026).
  • At NexLife, compounded semaglutide is $95 a month on the 12-month plan; it isn’t FDA-approved, and NexLife doesn’t offer Contrave.

At a glance

How are Contrave and semaglutide different?

Contrave is a twice-daily pill that combines naltrexone and bupropion; semaglutide is a GLP-1 medicine, sold for weight as Wegovy, a weekly shot or a pill. In separate trials, people lost more weight on Wegovy, and Contrave usually costs less. Each has a boxed warning. Searching “Contrave vs. Ozempic”? Ozempic is Novo Nordisk’s semaglutide for type 2 diabetes. Using it for weight loss is off-label, and NovoCare fills it only for a use on its label.

From the labels (Contrave, November 2025; Wegovy, June 2026 and June 2021), contrave.com, wegovy.com, NovoCare and Medicare.gov, checked November 1, 2026. Separate trials, not head-to-head. These trials studied FDA-approved Contrave and Wegovy; compounded semaglutide wasn’t studied.
ContraveSemaglutide (Wegovy)
What it isNaltrexone plus bupropion, in one extended-release tabletSemaglutide, a GLP-1 medicine from Novo Nordisk
FDA-approved forWeight in adults with obesity, or overweight with a weight-related condition (since September 10, 2014). Not for childrenWeight in adults (since 2021) and children 12 and older, heart risk in adults with heart disease, and MASH
How you take itTablets by mouth: 1 a day in week 1, building to 2 in the morning and 2 in the evening from week 4A shot once a week, or a pill (30 tablets a month)
DoseUp to 32 mg of naltrexone and 360 mg of bupropion a day0.25 mg to 2.4 mg a week, in 4-week steps; 7.2 mg for some adults
Main trialname and yearCOR-I (56 weeks; 2010): 5.4% average weight loss, vs 1.3% on placeboSTEP 1 (68 weeks, 2021): 14.9% average weight loss, vs 2.4% on placebo
Most common side effectslabel, vs placeboNausea 32.5% (6.7%), constipation 19.2% (7.2%), headache 17.6% (10.4%)Nausea 44% (16%), diarrhea 30% (16%), vomiting 24% (6%)
Boxed warningSuicidal thoughts and behaviors, from its antidepressant ingredientThyroid C-cell tumors, seen in rodents
Self-pay pricechecked November 1, 2026$99 a month by home delivery; $199 for 120 tablets at a retail pharmacy if not covered$349 a month for the pen ($399 HD); the pill $149 to $299; $199 for each of a new patient’s first two fills through December 31, 2026
Insurance and Medicare, 2026–2027Savings card as low as $0 with private insurance that covers it. Medicare Part D and TRICARE patients pay cashSavings card as little as $25 with coverage. Medicare’s GLP-1 Bridge: $50 a month if you qualify, through December 31, 2027

From the labels (Contrave, November 2025; Wegovy, June 2026 and June 2021), contrave.com, wegovy.com, NovoCare and Medicare.gov, checked November 1, 2026. Separate trials, not head-to-head. These trials studied FDA-approved Contrave and Wegovy; compounded semaglutide wasn’t studied.

How they work

How do Contrave and semaglutide work: cravings or appetite?

Differently. Contrave, a twice-daily pill, combines naltrexone and bupropion; its label points to the brain’s reward system as well as its appetite center. Semaglutide is a GLP-1 medicine, a weekly shot or a pill; its label points to appetite, calorie intake and a slower stomach.

  • Contrave: two medicines in one tablet

    Naltrexone blocks opioids. Bupropion, the ingredient in some antidepressants, weakly blocks the reuptake of dopamine and norepinephrine. Lab studies suggest that together they act on the hypothalamus, the brain’s appetite center, and on its reward system. Its label says the exact effects aren’t fully understood.

  • Semaglutide: a GLP-1 medicine

    It acts like GLP-1, a hormone that regulates appetite and calorie intake, in brain areas that control appetite. Wegovy’s label says it lowers how much people eat, likely through appetite, and slows how fast the stomach empties.

Cravings or appetite? Contrave’s label points to the brain’s reward system as well as its appetite center; Wegovy’s points to appetite and calorie intake. Both describe how the medicines act, not what you’ll feel. If cravings are what you struggle with most, tell your provider: it’s part of choosing.

Results

Contrave or semaglutide: which led to more weight loss in trials?

Wegovy, in separate trials: people lost 14.9% on average in its STEP 1 trial, against 5.4% on Contrave in COR-I, while placebo groups lost 2.4% and 1.3%. The trials differed in length, people and support (STEP 1 ran 68 weeks, COR-I 56), and neither label reports a head-to-head trial.

Separate trials, not head-to-head. Contrave: its label (revised November 2025), which reports COR-I, COR-BMOD and COR-Diabetes. Wegovy: its June 2021 label, where STEP 1, STEP 2 and STEP 3 are Studies 1, 2 and 3, and Novo Nordisk’s approval release (June 4, 2021), which names STEP 1. Years are the journal publications: COR-I in The Lancet, COR-BMOD in Obesity, COR-Diabetes in Diabetes Care, STEP 1 in The New England Journal of Medicine, STEP 2 in The Lancet and STEP 3 in JAMA. These trials studied FDA-approved Contrave and Wegovy; compounded semaglutide wasn’t studied.
TrialWho took partAverage weight changeLost 5% or more
Contrave, COR-I56 weeks; 2010Adults with obesity, or overweight with a condition; diet and counseling−5.4% (placebo −1.3%)42% (placebo 17%)
Contrave, COR-BMOD56 weeks; 2011The same, plus 28 group behavior sessions−8.1% (placebo −4.9%)57% (placebo 43%)
Contrave, COR-Diabetes56 weeks; 2013Adults with type 2 diabetes and a BMI over 27−3.7% (placebo −1.7%)36% (placebo 18%)
Wegovy, STEP 168 weeks; 2021Adults with obesity or overweight, without diabetes−14.9% (placebo −2.4%)83.5% (placebo 31.1%)
Wegovy, STEP 368 weeks; 2021Adults without diabetes, with intensive behavioral therapy and an 8-week low-calorie diet−16.0% (placebo −5.7%)84.8% (placebo 47.8%)
Wegovy, STEP 268 weeks; 2021Adults with type 2 diabetes−9.6% (placebo −3.4%)67.4% (placebo 30.2%)

Swipe the table sideways to see every column.

Separate trials, not head-to-head. Contrave: its label (revised November 2025), which reports COR-I, COR-BMOD and COR-Diabetes. Wegovy: its June 2021 label, where STEP 1, STEP 2 and STEP 3 are Studies 1, 2 and 3, and Novo Nordisk’s approval release (June 4, 2021), which names STEP 1. Years are the journal publications: COR-I in The Lancet, COR-BMOD in Obesity, COR-Diabetes in Diabetes Care, STEP 1 in The New England Journal of Medicine, STEP 2 in The Lancet and STEP 3 in JAMA. These trials studied FDA-approved Contrave and Wegovy; compounded semaglutide wasn’t studied.

Closer pairs, still separate trials. With an intensive behavior program, Contrave averaged 8.1% at 56 weeks (COR-BMOD, 2011) and Wegovy 16.0% at 68 weeks (STEP 3, 2021). STEP 3 also began with an 8-week low-calorie diet. In type 2 diabetes, the figures were 3.7% (COR-Diabetes, 2013) and 9.6% (STEP 2, 2021). In COR-Diabetes, A1c fell 0.6 points on Contrave, against 0.1 on placebo.

Many people stopped early. The four COR trials had 4,536 people, its 2014 approval announcement says. In them, 46% on Contrave and 45% on placebo left before week 56, most in the first 12 weeks.

Which fits you

Contrave or semaglutide: which is right for you?

Your history often decides it before results or price do. Six situations, from the labels:

  • If you take opioids, or may need them

    Contrave isn’t for long-term opioid use or opioid withdrawal: its naltrexone blocks opioids. For a short-term need, its label says to pause it. After regular use of short-acting opioids, its label recommends at least 7 to 10 days without them before starting Contrave. After buprenorphine or methadone, it can be up to two weeks.

  • If you’ve had seizures or an eating disorder

    Contrave’s label rules it out with a seizure disorder or history of seizures, and with bulimia or anorexia. About 1 in 1,000 people had a seizure in its trials.

  • If your blood pressure runs high

    Uncontrolled high blood pressure rules out Contrave. It can raise blood pressure and pulse slightly, so both are checked before and during treatment.

  • If you have depression or another mood condition

    Contrave isn’t approved to treat depression. Anyone starting it should be watched for new or worse suicidal thoughts, its boxed warning says. Its label also warns about mania.

  • If you’d rather not inject

    Contrave is a pill. So is the Wegovy pill, at $149 to $299 a month self-pay. More: GLP-1 pills vs. injections.

  • If cost decides it

    Contrave is $99 a month by home delivery, and Wegovy is $349 self-pay. Compounded semaglutide, which isn’t FDA-approved, runs $87 to $399 a month, month to month and all in, in our GLP-1 price index (median $199, checked Nov. 15, 2026). At NexLife it’s $95 a month on the 12-month plan or $109 month to month; every price is in the cost table below.

With Medicare? The $50 GLP-1 Bridge covers Wegovy for people who qualify, not Contrave. Contrave’s program treats Medicare Part D patients as cash payers at $99. Who qualifies for the Bridge.

“Starting July 1, 2026, Medicare will begin a short-term demonstration, called the Medicare GLP-1 Bridge, that will provide eligible Medicare Part D beneficiaries with access to certain GLP-1 drugs.”

Centers for Medicare & Medicaid Services, Medicare GLP-1 Bridge, last modified July 13, 2026

Step by step

How do you choose between Contrave and semaglutide?

Your history often decides it before results or price do. Start there, then compare the trials, side effects and cost with your provider.

  1. Check what each is approved for. Contrave is FDA-approved for weight in adults with obesity, or overweight with a weight-related condition. Wegovy is approved for weight in adults and children 12 and older, for heart risk in adults with heart disease, and for MASH.
  2. Start with your health history. Contrave isn’t for people with uncontrolled high blood pressure, seizures, bulimia or anorexia, or long-term opioid use. Semaglutide isn’t for anyone with a personal or family history of medullary thyroid carcinoma, or with MEN 2.
  3. Compare the trial results. In separate trials, Contrave averaged 5.4% weight loss at 56 weeks (COR-I) and Wegovy 14.9% at 68 weeks (STEP 1), against 1.3% and 2.4% on placebo. Averages aren’t promises. Compounded semaglutide wasn’t studied.
  4. Weigh the side effects. Nausea leads on both: 32.5% on Contrave and 44% on Wegovy 2.4 mg, against 6.7% and 16% on placebo. Contrave’s boxed warning is suicidal thoughts and behaviors; semaglutide’s is thyroid C-cell tumors, seen in rodents.
  5. Compare what you’d pay. Contrave is $99 a month by home delivery and Wegovy pens $349 self-pay. Medicare’s $50 GLP-1 Bridge covers Wegovy if you qualify, not Contrave. Compounded semaglutide isn’t FDA-approved; at NexLife, it’s $95 a month on the 12-month plan.
  6. Decide with your provider. Your provider reviews your history against the full labels and sets the timing of any switch; Wegovy starts at 0.25 mg a week and steps up every 4 weeks. Don’t combine the two on your own.

The trials were separate, not head-to-head, and prices were checked November 1, 2026; your provider decides what fits your history.

Side effects

Contrave vs. semaglutide side effects: how do they compare?

Nausea leads on both: 32.5% on Contrave and 44% on Wegovy 2.4 mg, against 6.7% and 16% on placebo. Headache, dizziness, trouble sleeping and dry mouth stand out on Contrave’s list; diarrhea and vomiting on Wegovy’s. Each drug also has a boxed warning.

Not head-to-head. Contrave: five pooled placebo-controlled trials of up to 56 weeks, 2,545 people on the full dose and 1,515 on placebo (its label, November 2025). Wegovy: three trials of up to 68 weeks (its label, June 2026, Table 3). These trials studied FDA-approved Contrave and Wegovy; compounded semaglutide wasn’t studied.
Side effectContrave vs placeboWegovy 2.4 mg vs placebo
Nausea32.5% vs 6.7%44% vs 16%
Constipation19.2% vs 7.2%24% vs 11%
Headache17.6% vs 10.4%14% vs 10%
Vomiting10.7% vs 2.9%24% vs 6%
Dizziness9.9% vs 3.4%8% vs 4%
Trouble sleepinginsomnia9.2% vs 5.9%Not in its main table
Dry mouth8.1% vs 2.3%Not in its main table
Diarrhea7.1% vs 5.2%30% vs 16%
Tirednessfatigue4.0% vs 3.4%11% vs 5%
Belly painabdominal pain2.8% vs 1.4%20% vs 10%
Stopped because of a side effect24% vs 12%6.8% vs 3.2%

Not head-to-head. Contrave: five pooled placebo-controlled trials of up to 56 weeks, 2,545 people on the full dose and 1,515 on placebo (its label, November 2025). Wegovy: three trials of up to 68 weeks (its label, June 2026, Table 3). These trials studied FDA-approved Contrave and Wegovy; compounded semaglutide wasn’t studied.

Stopping. One in four people on Contrave stopped because of a side effect, against 12% on placebo; nausea was the most common reason, at 6.3%. On Wegovy, 6.8% stopped, against 3.2%.

Blood pressure and pulse. In Contrave’s trials, blood pressure ran about 2 points higher than on placebo in the first 12 weeks. Pulse ran about 2 beats a minute faster.

Meals that go easier on your stomach: what to eat on a GLP-1.

Who shouldn’t

Who shouldn’t take Contrave or semaglutide?

Each has a boxed warning. Contrave’s list of people who shouldn’t take it is longer, because of its two ingredients.

From the Contrave label (revised November 2025), the Wegovy label (revised June 2026) and the FDA’s Nov. 9, 2026, NAION safety communication. Your provider reviews your history against the full labels.
ContraveSemaglutide (Wegovy)
Boxed warningSuicidal thoughts and behaviors. Antidepressants raised them in children, teens and young adults in short-term trials (not seen over age 24). Everyone starting Contrave should be watched for new or worse thoughtsThyroid C-cell tumors in rodents. It isn’t known whether semaglutide causes them in people
Don’t take it ifYou have uncontrolled high blood pressure, seizures, bulimia or anorexia; take another bupropion product, opioids long term or an MAOI in the past 14 days; are in opioid withdrawal; are suddenly stopping alcohol, benzodiazepines, barbiturates or seizure medicines; or are allergic to either ingredientYou or a family member had medullary thyroid carcinoma, you have MEN 2, or you’ve had a serious allergy to semaglutide
Other label warningsSeizures, blood pressure and pulse, liver injury, mania, angle-closure glaucoma, and low blood sugar with insulin or a sulfonylureaPancreatitis, gallbladder disease, low blood sugar with insulin or a sulfonylurea, kidney injury from dehydration, eye changes in type 2 diabetes, a faster heart rate, and aspiration under anesthesia. The FDA also warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare optic nerve problem that can cause sudden, painless vision loss in one eye; call your provider right away if that happens (FDA)
PregnancyWeight loss offers no benefit in pregnancy and may harm the baby, its label says; stop it once you know you’re pregnantStop at least 2 months before a planned pregnancy

Swipe the table sideways to see every column.

From the Contrave label (revised November 2025), the Wegovy label (revised June 2026) and the FDA’s Nov. 9, 2026, NAION safety communication. Your provider reviews your history against the full labels.

When to get help right away. Thoughts of suicide or self-harm: call or text 988, any time. Signs of liver problems on Contrave: its label says to stop it if hepatitis is suspected, so call your provider. On semaglutide, severe stomach pain that won’t go away can mean pancreatitis: stop and call your provider. For a seizure or a serious allergic reaction, call 911.

Cost

What do Contrave and semaglutide cost, every way to pay?

Self-pay, Contrave costs least through its own home-delivery program: $99 a month, or about $89 a month in its 3-month starter bundle; Wegovy pens are $349 self-pay (checked November 1, 2026). NexLife’s compounded semaglutide, not FDA-approved, is $95 a month on the 12-month plan.

Prices from contrave.com (page modified July 6, 2026), NovoCare’s terms, wegovy.com and Medicare.gov, checked November 1, 2026. Contrave’s full dose is 4 tablets a day, so 120 tablets is a month. NexLife’s price is the same at every dose.
How you payA monthA year, or what to know
Contrave, Contrave Connex home delivery (formerly CurAccess)insured or not; $99 or less$99$1,188
Contrave starter bundle3 months by home delivery$267 for 3 months (about $89 a month)A starter bundle
Contrave at a retail pharmacysavings card, private insurance that covers itAs low as $0Depends on your plan
Contrave at a retail pharmacynot covered: cash price with the card$199 for 120 tablets$2,388
Wegovy pen, NovoCare self-pay0.25 mg to 2.4 mg; a month is 28 days$349$4,537 (13 fills)
Wegovy HD 7.2 mg, self-pay$399$5,187 (13 fills)
Wegovy, new patientsfirst two fills at 0.25 or 0.5 mg$199 eachThrough December 31, 2026
Wegovy pill, NovoCare self-pay30 tablets$149 to $299, by dose$3,588 at $299, the 25 mg maintenance dose’s price
Wegovy savings cardcommercial insurance that covers WegovyAs little as $25 (up to $100 off)Not for government plans
Medicare GLP-1 BridgeWegovy, if you qualify; not Contrave$50Through December 31, 2027
Compounded semaglutide, NexLife12-month plan; not FDA-approved$95$1,140
Compounded semaglutide, NexLifemonth to month; not FDA-approved$109$1,308

NexLife Price Match Guarantee†. Already on compounded semaglutide with another licensed provider, and paying less? We match your regular monthly price. How it works

Swipe the table sideways to see every column.

Prices from contrave.com (page modified July 6, 2026), NovoCare’s terms, wegovy.com and Medicare.gov, checked November 1, 2026. Contrave’s full dose is 4 tablets a day, so 120 tablets is a month. NexLife’s price is the same at every dose.

On the Bridge’s price, Medicare.gov says:

“You’ll pay a $50 copayment to the pharmacy for a one-month supply (either 28 or 30 days, depending on drug).”

Centers for Medicare & Medicaid Services, Weight loss drugs | Medicare

The gap, in numbers. A year of Contrave at $99 is $1,188. A year of Wegovy pens, 13 four-week fills at $349, is $4,537. Compounded semaglutide at NexLife is $1,140 a year on the 12-month plan. Compounded semaglutide isn’t FDA-approved, isn’t a generic and wasn’t studied in Wegovy’s trials.

Who can use Contrave’s program? No insurance is needed, and people with Medicaid, Medicare Part D or TRICARE can use it as cash payers, subject to eligibility. Its online-visit route adds a $45 fee if you’re prescribed, and isn’t offered in Louisiana.

NexLife’s Price Match Guarantee† covers compounded semaglutide and tirzepatide from another licensed U.S. telehealth provider, not Contrave. More ways to pay for semaglutide: semaglutide without insurance and Wegovy’s 2027 prices.

Together

Can you take Contrave and semaglutide together?

Not as an FDA-approved combination: Contrave and semaglutide haven’t been studied as a pair, so your provider decides. Each has its own boxed warning: suicidal thoughts and behaviors for Contrave, from bupropion, and thyroid C-cell tumors in rodents for semaglutide.

  1. What the labels say

    Wegovy’s label advises against combining it with other semaglutide products or other GLP-1 medicines. Contrave’s rules out other bupropion products and advises against other naltrexone products. Neither label tested the two together. Semaglutide also slows stomach emptying, which can change how pills you take by mouth are absorbed, Wegovy’s label says.

  2. Side effects that overlap

    Nausea is the most common side effect of both, and constipation is common on both. That matters if a provider considers using them together.

  3. Low blood sugar with diabetes

    Both labels warn that, with insulin or a sulfonylurea, blood sugar can drop too low; your provider may lower those doses.

  4. Who decides

    Your provider, after reviewing everything you take. Don’t combine them, or add either to another weight-loss medicine, on your own.

Switching

How do you switch between Contrave and semaglutide?

Your provider sets any switch. Here’s what each label says about starting and stopping.

The details
Starting ContraveOne tablet in the morning in week 1, building to 2 tablets twice a day from week 4. Swallow them whole, and not with a high-fat meal.
The 12-week checkAfter 12 weeks at the full dose, its label says to stop Contrave if you haven’t lost at least 5% of your starting weight.
After stopping ContraveYou may be more sensitive to opioids, even at lower doses, its label warns.
Starting Wegovy0.25 mg once a week, rising every 4 weeks through 0.5, 1 and 1.7 mg, to a maintenance dose from week 17.
Kidney or liver problemsContrave’s maximum is 1 tablet twice a day with moderate liver problems or moderate to severe kidney problems. Its label doesn’t recommend it with end-stage kidney disease or severe liver problems.

Moving to compounded semaglutide? It isn’t FDA-approved, and a licensed provider decides if it’s right for you, and when to start. More: compounded semaglutide, explained.

“Compounded drugs are not FDA-approved. This means that FDA does not verify the safety, effectiveness or quality of compounded drugs before they are marketed.”

U.S. Food and Drug Administration, Compounding and the FDA: Questions and Answers

At NexLife

Considering compounded semaglutide instead? NexLife, in short

One price at every dose, and a licensed provider who decides if it’s right for you. NexLife’s providers prescribe compounded semaglutide for weight loss. It isn’t a treatment for type 2 diabetes and doesn’t replace Ozempic or your diabetes care.

  1. What NexLife offers

    Compounded semaglutide and compounded tirzepatide only, so not Contrave. You start with an online assessment of about 3 minutes, and a licensed provider decides if treatment is right for you. Not prescribed? No charge for medication.

  2. The price

    $95 a month on the 12-month plan, $99 on 6 months, $105 on 3 months or $109 month to month, the same at every dose, with no membership fee. Compounded semaglutide isn’t FDA-approved or a generic, and it’s prescribed only when it offers a significant difference for you.

  3. Who fills it, and how you pay

    Absolute Pharmacy (Lutz, FL) or Boudreaux’s New Drug Store (Lake Charles, LA), state-licensed 503A partner pharmacies, with free shipping. Pay by HSA or FSA card, or with Affirm, Klarna or Afterpay; with Medicare, you can pay yourself.

  4. Care between refills

    A licensed provider who follows your dose, a nutrition plan and a 1:1 coaching call. Real people answer 24/7 at (949) 818-8000.

Paying less for compounded semaglutide elsewhere? Send a receipt from the last 60 days, and we’ll match the regular monthly price you pay another licensed U.S. telehealth provider. Price Match Guarantee†

Rated 4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026), and LegitScript-certified. Medical director: Adam Kennah, MD, board-certified in emergency medicine by the American Board of Emergency Medicine.

Vial math

How many units is your semaglutide dose?

Your semaglutide dose in units depends on your vial’s strength. Here are the Wegovy label’s dose steps at two example strengths.

Semaglutide dose steps from the Wegovy label, with the volume and units on a U-100 syringe at two example strengths, 2.5 mg/mL and 5 mg/mL
WeeksWeekly doseAt 2.5 mg/mLAt 5 mg/mL
1 to 40.25 mg0.1 mL (10 units)0.05 mL (5 units)
5 to 80.5 mg0.2 mL (20 units)0.1 mL (10 units)
9 to 121 mg0.4 mL (40 units)0.2 mL (20 units)
13 to 161.7 mg0.68 mL (68 units)0.34 mL (34 units)
17 onward2.4 mg0.96 mL (96 units)0.48 mL (48 units)

The math: mL = dose ÷ strength (mg per mL); units = mL × 100. At 2.5 mg/mL, 1 mg is 1 ÷ 2.5 = 0.4 mL, or 40 units. At 5 mg/mL, the same 1 mg is 0.2 mL, or 20 units.

Both strengths are examples only. The same dose is a different number of units at a different strength, so read the strength on your own vial’s label. Your prescription sets your dose and schedule, which may differ from these label steps. Every step: the semaglutide dosage chart. Or enter your own vial’s strength in the semaglutide dosage calculator.

Loved by our members

Real stories from NexLife members about their care and service.

A selection of 5-star reviews from Trustpilot, quoted in full as written. Results vary from person to person, and weight loss isn’t guaranteed.

★★★★★TrustScore 4.8 out of 5 on Trustpilot407 reviews as of Nov. 15, 2026 · Read them all ↗

  • ★★★★★Read on Trustpilot ↗

    “That’s a real site with good prices and plans!”

    Estefany L.

  • ★★★★★Read on Trustpilot ↗

    “Affordable, quick and easy. They could not have made it a smoother less stressful experience.”

    Andisheh K.

  • ★★★★★Read on Trustpilot ↗

    “Great communication. Easy to work with. They work to set you up for success.”

    Anthony C.

  • ★★★★★Read on Trustpilot ↗

    “Fast delivery and easy to get a hold of when needing to talk with someone!”

    Browneyes

  • ★★★★★Read on Trustpilot ↗

    “So happy with NexLife. Communication has been great, I’m recommending them to all my friends.”

    April

  • ★★★★★Read on Trustpilot ↗

    “Excellent visit. Dr. Kennah was very knowledgeable and helpful and answered all my questions.”

    Ethan B.

  • ★★★★★Read on Trustpilot ↗

    “Very happy so far”

    Tammy E.

  • ★★★★★Read on Trustpilot ↗

    “Fast service great communication!! Willing to work with you!”

    Bon

  • ★★★★★Read on Trustpilot ↗

    “Great service and excellent communication!”

    Gabrielle D.

  • ★★★★★Read on Trustpilot ↗

    “Easy and pricing not bad! Customer service was helpful in answering my questions.”

    Lyndy T.

  • ★★★★★Read on Trustpilot ↗

    “Good experience, great team”

    Mai S.

  • ★★★★★Read on Trustpilot ↗

    “Great communciation and was fast and reliable”

    Kiki

Names are shortened for privacy. Reviews are members’ opinions, not medical advice.

What does NexLife cost?
One flat price at every dose.

No membership fee. Provider care, a nutrition plan, coaching and shipping are included. Paying less with another licensed provider? We match your regular monthly price.†

Illustration of a compounded tirzepatide vialGIP + GLP-1

12-month plan $115/mo

Tirzepatide

Weekly and dual-action. Care, coaching and shipping included. On a 12-month plan, $1,380 paid upfront; $129/mo month to month, billed monthly.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

Illustration of a compounded semaglutide vialGLP-1

12-month plan $95/mo

Semaglutide

Weekly GLP-1. Care, coaching and shipping included. On a 12-month plan, $1,140 paid upfront; $109/mo month to month, billed monthly.

Check my eligibility

Compounded, not FDA-approved · Not prescribed? No charge for medication

TrustScore 4.8 out of 5 on Trustpilot 407 reviews as of Nov. 15, 2026 · Read them all ↗

Compounded, not FDA-approved. A licensed provider prescribes it only when it offers a significant difference for you. Vials shown are illustrations. Always use the strength on your pharmacy’s label. Every plan and price · Price Match Guarantee† terms

The NexLife Price Match Guarantee†

Paying less elsewhere?
Keep your price. Upgrade your care.

Already on compounded tirzepatide or semaglutide? Pay less with another licensed U.S. telehealth provider or clinic, and we match your regular monthly price for as long as your plan stays active.† Plus a provider who follows your dose, a nutrition plan, a coaching call and real people 24/7.

  1. 1Send a receipt from the last 60 days
  2. 2A NexLife provider reviews your prescription
  3. 3Pay your matched price, at every dose
Switch and keep my price

Locked while your plan is activeSame price at every doseNo membership fee

†Terms: see the Price Match Guarantee† details below. Compounded medications aren’t FDA-approved; a provider prescribes one only when it offers a significant difference for you.

Contrave vs. semaglutide: your questions

Fair questions about NexLife

Will my price go up with my dose?
No. You pay the same at every dose.
What if I’m not prescribed?
You aren’t charged for medication.
Can I cancel?
Yes, by email. It takes effect 30 days after we receive it. Plans renew until you cancel; our cancellation policy has the details.
Do I need insurance?
No. Pay with an HSA or FSA card, or with Affirm, Klarna or Afterpay at checkout.

Can you take Contrave and semaglutide together?

They haven’t been studied as a pair: neither label tested them together, and the FDA hasn’t approved the combination. Wegovy’s label advises against other semaglutide or GLP-1 medicines; Contrave’s rules out other bupropion products and advises against other naltrexone products. Whether to combine them is your provider’s decision.

Can you take Contrave if you take opioids?

Not if you take them regularly. Contrave contains naltrexone, which blocks opioids, and its label rules it out with long-term opioid use or opioid withdrawal. For a short-term opioid need, Contrave is paused. Taking large opioid doses to overcome the block can be fatal, the label warns.

Who shouldn’t take Contrave or semaglutide?

Contrave isn’t for people with uncontrolled high blood pressure, seizures, bulimia or anorexia, long-term opioid use, or another bupropion product. Semaglutide isn’t for anyone with a personal or family history of medullary thyroid carcinoma, or with MEN 2. Each label lists more cautions, and your provider reviews them with you.

Does insurance cover Contrave or semaglutide?

It depends on your plan. With private insurance that covers them, Contrave’s savings card can bring it as low as $0 and Wegovy’s as little as $25. Medicare’s $50 GLP-1 Bridge covers Wegovy for people who qualify, not Contrave; Contrave’s program treats Medicare Part D patients as cash payers at $99.

How much does Contrave cost compared with semaglutide?

Contrave, a twice-daily pill, is $99 a month through its home-delivery program; Wegovy, a weekly semaglutide shot, is $349 self-pay (November 1, 2026). A year of Contrave at $99 is $1,188; a year of Wegovy pens is $4,537 for 13 fills. Compounded semaglutide, which isn’t FDA-approved, is $1,140 a year at NexLife on the 12-month plan.

Can I switch from Contrave to semaglutide?

Yes, if your provider agrees; they set the timing. Wegovy starts at 0.25 mg a week and steps up every 4 weeks. Contrave’s label says to stop it if you haven’t lost 5% after 12 weeks at the full dose, and that you may be more sensitive to opioids after stopping.

How fast do Contrave and semaglutide work?

Both take months to judge. Contrave reaches its full dose in week 4, and its label says to check your weight after 12 weeks at that dose. Wegovy steps up every 4 weeks to its maintenance dose at week 17. Their main trials measured results at 56 and 68 weeks.

Is Contrave or semaglutide better for cravings?

It isn’t settled. Contrave’s label describes effects on the brain’s appetite center and reward system, from lab studies, while Wegovy’s describes appetite and calorie intake. The main trial results for both are about weight, so which helps your cravings more is something to work out with your provider.

Which has more side effects, Contrave or semaglutide?

Different ones. Nausea led on both: 32.5% on Contrave and 44% on Wegovy 2.4 mg, against 6.7% and 16% on placebo. Headache, dizziness, insomnia and dry mouth stand out on Contrave’s list; diarrhea and vomiting on Wegovy’s. In separate trials, more people stopped Contrave for side effects, 24% against 6.8%. Compounded semaglutide wasn’t studied.

Is Contrave or semaglutide better for weight loss?

In separate trials, people lost more on semaglutide. In COR-I (2010), Contrave averaged 5.4% at 56 weeks, against 1.3% on placebo; in STEP 1 (2021), Wegovy averaged 14.9% at 68 weeks, against 2.4%. Neither label reports a head-to-head trial. These trials studied FDA-approved Contrave and Wegovy; compounded semaglutide wasn’t studied.

Is Contrave a GLP-1?

No. Contrave is a pill that combines naltrexone, which blocks opioids, and bupropion, the ingredient in some antidepressants. Lab studies suggest they act on the brain’s appetite center and reward system. Semaglutide is the GLP-1 medicine; for weight, it’s sold as Wegovy, a weekly shot or a pill.

How does Contrave compare with Ozempic?

Ozempic contains semaglutide, the medicine this page compares with Contrave, but it’s Novo Nordisk’s version for type 2 diabetes. Using it for weight loss is off-label, and NovoCare fills it only for a use on its label. For weight, semaglutide is sold as Wegovy, a weekly shot or a pill.

Does Contrave raise blood pressure?

It can, slightly. In Contrave’s trials, blood pressure ran about 2 points higher than on placebo in the first 12 weeks, and pulse about 2 beats a minute faster. Uncontrolled high blood pressure rules out Contrave, and both are checked before and during treatment.

Important safety information

Compounded tirzepatide and semaglutide are not FDA-approved, and the FDA hasn’t reviewed them for safety, effectiveness or quality. A provider prescribes them only when they offer a significant difference for you compared with an FDA-approved product. Both medicines may cause thyroid tumors, including cancer: don’t use either if you or a family member has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). The most common side effects include nausea, diarrhea, vomiting, constipation and stomach pain.

Read the full safety information

In studies with rodents, both medicines caused thyroid tumors; it isn’t known whether they cause them in people. Tell your provider if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath. Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and a faster heart rate. The FDA warned on Nov. 9, 2026, that GLP-1 medicines may raise the risk of NAION, a rare eye condition that can cause sudden vision loss in one eye; call your provider right away if that happens (FDA). Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don’t combine either medicine with other GLP-1 medicines.

Tirzepatide can make birth control pills less effective: switch to a non-oral method, or add a barrier method such as condoms, for 4 weeks after you start and for 4 weeks after each dose increase. Both medicines may harm an unborn baby. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your provider right away if you’re pregnant, planning to be, or breastfeeding.

This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your provider. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.

† NexLife Price Match Guarantee: for new NexLife members switching from a licensed U.S. telehealth provider or clinic with an active prescription for compounded tirzepatide or semaglutide. We match your regular all-in monthly price there (medication plus any required membership, program or visit fee, on a month-to-month plan); first-month offers, coupons, referral credits and prepaid multi-month rates aren’t matched. Proof from the last 60 days required. A licensed provider must determine that treatment is right for you. Not open to people with Medicare, Medicaid or TRICARE coverage. Full terms.

About NexLife. NexLife is a telehealth and care-coordination platform. Care is delivered through affiliated, physician-owned medical groups, and licensed providers decide whether treatment is right for you. NexLife doesn’t make or compound medication: state-licensed partner pharmacies fill each prescription, and we coordinate the rest. Available only in states where our affiliated providers are licensed.

Who wrote and medically reviewed this page?

Adam Kennah, MDMedical Director, NexLife · Board-certified in emergency medicine (American Board of Emergency Medicine) · NPI 1144260043

Leads the NexLife Medical Team, which writes and medically reviews NexLife’s guides, including this one.

NexLife Medical TeamWrites and updates NexLife’s guides

Labels, approval records, prices and Medicare’s rules checked Nov. 1, 2026; price-index figures checked Nov. 15, 2026.

  • How we checked. Every clinical fact here comes from the Contrave and Wegovy labels, the FDA’s 2014 approval letter, the makers’ approval announcements and the COR-Diabetes paper’s record, read on November 1, 2026. Prices come from contrave.com, NovoCare’s terms and wegovy.com, and Medicare’s rules from Medicare.gov and CMS, checked the same day; compounded prices come from our GLP-1 price index, checked Nov. 15, 2026. Each trial result carries its trial, its length, its year and its source, and the trials are never added up as if they were one. Contrave is a trademark of its owner; Wegovy and Ozempic are trademarks of Novo Nordisk. NexLife isn’t affiliated with either.
  • Every fact, sourced. Each price and rule links to the page it comes from.
  • How we make money. NexLife is a telehealth and care-coordination platform. We earn revenue when people join NexLife.
  • Corrections, fast. See something wrong or out of date? Email hello@nexlife.us and we’ll fix it.
  • How we work. How we review programs · GLP-1 price index · Is NexLife legit? · States NexLife serves

Paying less elsewhere? We match it.†

Comparing your options? Start with a 3-minute check.

A licensed provider decides if compounded semaglutide is right for you. It’s $95 a month on the 12-month plan, or $109 month to month, at every dose.

4.8 out of 5 on Trustpilot, 407 reviews (read Nov. 15, 2026) · Medical director Adam Kennah, MD (NPI 1144260043) · LegitScript-certified

Compounded medications aren’t FDA-approved. A provider prescribes one only when it offers a significant difference for you.

  1. 1
    Tell us about you

    Start online with your health history.

  2. 2
    A licensed provider decides

    Online, following your state’s rules. You’re prescribed only if treatment is right for you.

  3. 3
    We ship it, then stay with you

    Our partner pharmacy usually ships within 1 to 2 business days. Free shipping, and questions come to us 24/7, never to the pharmacy.